Analyst: This Drug Stock Could Double

Penny stock APTO scored a new "buy" rating today

Nov 16, 2018 at 11:22 AM
facebook X logo linkedin


The shares of penny stock Aptose Biosciences Inc (NASDAQ:APTO) are higher today, after B. Riley FBR initiated coverage with a "buy" rating. What's more, the analyst issued a $5 price target -- more than double APTO stock's current price -- and waxed optimistic on the company's "two unique first-in-class" leukemia drugs. As such, Aptose Biosciences stock was last seen 5.6% higher to trade at $2.17.

APTO stock notched a three-year high of $4.55 on June 18, but has since surrendered more than half its value. Recent rebound attempts have stalled in the face of the formerly supportive 50-day moving average, and the shares are also still staring up at their year-to-date breakeven of $2.24 -- the site of today's intraday peak, in fact.

APTO stock chart nov 16

While absolute options volume tends to run light on Aptose -- the drugmaker has seen just five calls and zero puts bought to open in the past five days on the International Securities Exchange (ISE), Chicago Board Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX) -- calls have definitively been the option of choice among APTO speculators. In fact, looking at open interest data, the January 2019 and April 2.50 calls are most populated, with 375 and 359 contracts, outstanding, respectively. On the flip side, the most populated put strike is the April 2.50 put, with just 10 contracts open.

However, that call bias could be due to APTO stock's current price. The penny stock has little downside wiggle room at current levels, so the profit potential from buying a put is much more limited compared to the profit potential of a long call.

 

Target Effortless Triple-Digit Gains Every Sunday Evening For Life!

This is your chance to triple your profit potential on Sunday evenings, without spending all your free time watching the market.

On Sundays, as a Weekend Plus subscriber, you’ll get up to 6 trades every Sunday, each targeting gains of 200% or more.

Start targeting gains like the ones our subscribers have seen recently, including:

213.3% GAIN on AutoNation calls
100.0% GAIN on Monster Beverage calls
100.4% GAIN on Walgreens Boots Alliance puts
100.4% GAIN on ON Semiconductor calls
257.7% GAIN on Dell calls

101.0% GAIN on Apollo Global Management calls
103.6% GAIN on JP Morgan  Chase calls
105.3% GAIN on DraftKings calls
101.3% GAIN on Airbnb calls
203.0% GAIN on Shopify calls
102.0% GAIN on Cboe Global Markets calls
100.9% GAIN on Boeing calls
102.1% GAIN on Microsoft puts
102.3% GAIN on First Solar calls
101.5% GAIN on PulteGroup calls
101.0% GAIN on Apple calls
209.4% GAIN on NXP Semiconductors calls
100.8% GAIN on Uber Technologies calls
100.4% GAIN on Academy Sports and Outdoors puts
102.2% GAIN on Trade Desk calls
100.8% GAIN on DoorDash calls
100.0% GAIN on Camping World Holdings puts
100.0% GAIN on Cboe Global Markets calls
100.2% GAIN on C3.ai calls
238.5% GAIN on Oracle calls

 
 
 


 
 

Rainmaker Ads CGI